nodes	percent_of_prediction	percent_of_DWPC	metapath
Minocycline—CASP3—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTPRK—celiac disease	0.0171	0.0304	CbGpPWpGaD
Minocycline—SLC22A8—urine—celiac disease	0.0153	0.035	CbGeAlD
Minocycline—IL1B—IL23-mediated signaling events—IL23R—celiac disease	0.015	0.0266	CbGpPWpGaD
Minocycline—CASP1—connective tissue—celiac disease	0.0145	0.0331	CbGeAlD
Minocycline—IL1B—IL23-mediated signaling events—IL18RAP—celiac disease	0.0143	0.0253	CbGpPWpGaD
Minocycline—CYCS—connective tissue—celiac disease	0.0139	0.0319	CbGeAlD
Minocycline—CASP1—epithelium—celiac disease	0.0138	0.0315	CbGeAlD
Minocycline—CASP3—Allograft Rejection—IL21—celiac disease	0.0133	0.0237	CbGpPWpGaD
Minocycline—CASP3—Allograft Rejection—MICA—celiac disease	0.0133	0.0237	CbGpPWpGaD
Minocycline—CYCS—epithelium—celiac disease	0.0132	0.0303	CbGeAlD
Minocycline—CYCS—smooth muscle tissue—celiac disease	0.0128	0.0292	CbGeAlD
Minocycline—IL1B—Allograft Rejection—IL21—celiac disease	0.0121	0.0214	CbGpPWpGaD
Minocycline—IL1B—Allograft Rejection—MICA—celiac disease	0.0121	0.0214	CbGpPWpGaD
Minocycline—CASP3—connective tissue—celiac disease	0.0119	0.0273	CbGeAlD
Minocycline—CASP1—NOD1/2 Signaling Pathway—TNFAIP3—celiac disease	0.0118	0.021	CbGpPWpGaD
Minocycline—IL1B—Cytokines and Inflammatory Response—IL15—celiac disease	0.0118	0.021	CbGpPWpGaD
Minocycline—CYCS—pancreas—celiac disease	0.0118	0.027	CbGeAlD
Minocycline—IL1B—IL27-mediated signaling events—IL12A—celiac disease	0.0117	0.0208	CbGpPWpGaD
Minocycline—CASP3—epithelium—celiac disease	0.0113	0.0259	CbGeAlD
Minocycline—CASP3—smooth muscle tissue—celiac disease	0.0109	0.025	CbGeAlD
Minocycline—CASP1—lymphoid tissue—celiac disease	0.0106	0.0242	CbGeAlD
Minocycline—CASP1—Apoptosis—TNFRSF25—celiac disease	0.0106	0.0187	CbGpPWpGaD
Minocycline—CASP1—digestive system—celiac disease	0.0105	0.0239	CbGeAlD
Minocycline—CYCS—lymphoid tissue—celiac disease	0.0102	0.0233	CbGeAlD
Minocycline—CASP3—pancreas—celiac disease	0.0101	0.0231	CbGeAlD
Minocycline—CYCS—digestive system—celiac disease	0.0101	0.023	CbGeAlD
Minocycline—CASP1—blood—celiac disease	0.00997	0.0228	CbGeAlD
Minocycline—CASP1—Apoptosis Modulation and Signaling—TNFRSF25—celiac disease	0.0099	0.0176	CbGpPWpGaD
Minocycline—IL1B—IL12-mediated signaling events—IL18RAP—celiac disease	0.00969	0.0172	CbGpPWpGaD
Minocycline—CYCS—blood—celiac disease	0.00959	0.022	CbGeAlD
Minocycline—IL1B—connective tissue—celiac disease	0.00954	0.0218	CbGeAlD
Minocycline—IL1B—IL1 and megakaryotyces in obesity—CCR3—celiac disease	0.00944	0.0168	CbGpPWpGaD
Minocycline—VEGFA—Alpha9 beta1 integrin signaling events—TGM2—celiac disease	0.00926	0.0164	CbGpPWpGaD
Minocycline—IL1B—epithelium—celiac disease	0.00906	0.0207	CbGeAlD
Minocycline—CYCS—Apoptosis—TNFRSF25—celiac disease	0.00903	0.016	CbGpPWpGaD
Minocycline—CASP1—IFN-gamma pathway—PTPN2—celiac disease	0.00891	0.0158	CbGpPWpGaD
Minocycline—CASP3—lymphoid tissue—celiac disease	0.00873	0.02	CbGeAlD
Minocycline—IL1B—smooth muscle tissue—celiac disease	0.00873	0.02	CbGeAlD
Minocycline—CASP3—digestive system—celiac disease	0.00863	0.0197	CbGeAlD
Minocycline—VEGFA—smooth muscle tissue—celiac disease	0.00858	0.0196	CbGeAlD
Minocycline—CYCS—Apoptosis Modulation and Signaling—TNFRSF25—celiac disease	0.00847	0.015	CbGpPWpGaD
Minocycline—CASP3—blood—celiac disease	0.00822	0.0188	CbGeAlD
Minocycline—CASP1—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—TNFAIP3—celiac disease	0.00808	0.0144	CbGpPWpGaD
Minocycline—IL1B—pancreas—celiac disease	0.00807	0.0185	CbGeAlD
Minocycline—VEGFA—Allograft Rejection—MICA—celiac disease	0.00803	0.0143	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—IL21—celiac disease	0.00803	0.0143	CbGpPWpGaD
Minocycline—MMP9—connective tissue—celiac disease	0.00795	0.0182	CbGeAlD
Minocycline—VEGFA—pancreas—celiac disease	0.00794	0.0182	CbGeAlD
Minocycline—IL1B—IL27-mediated signaling events—IL17A—celiac disease	0.00789	0.014	CbGpPWpGaD
Minocycline—CASP1—liver—celiac disease	0.00779	0.0178	CbGeAlD
Minocycline—MMP9—epithelium—celiac disease	0.00755	0.0173	CbGeAlD
Minocycline—CYCS—liver—celiac disease	0.0075	0.0172	CbGeAlD
Minocycline—IL1B—Aryl Hydrocarbon Receptor Pathway—IL12A—celiac disease	0.0074	0.0131	CbGpPWpGaD
Minocycline—IL1B—TCR Signaling Pathway—ICOS—celiac disease	0.00734	0.013	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—TNFRSF25—celiac disease	0.00729	0.0129	CbGpPWpGaD
Minocycline—MMP9—smooth muscle tissue—celiac disease	0.00727	0.0166	CbGeAlD
Minocycline—MMP9—IL1 and megakaryotyces in obesity—CCR3—celiac disease	0.00724	0.0129	CbGpPWpGaD
Minocycline—IL1B—lymphoid tissue—celiac disease	0.00698	0.016	CbGeAlD
Minocycline—IL1B—digestive system—celiac disease	0.00689	0.0158	CbGeAlD
Minocycline—CASP3—Apoptosis Modulation and Signaling—TNFRSF25—celiac disease	0.00684	0.0121	CbGpPWpGaD
Minocycline—MMP9—pancreas—celiac disease	0.00672	0.0154	CbGeAlD
Minocycline—IL1B—blood—celiac disease	0.00656	0.015	CbGeAlD
Minocycline—CASP3—liver—celiac disease	0.00643	0.0147	CbGeAlD
Minocycline—ALOX5—connective tissue—celiac disease	0.00629	0.0144	CbGeAlD
Minocycline—IL1B—IL12-mediated signaling events—IL12A—celiac disease	0.00599	0.0106	CbGpPWpGaD
Minocycline—IL1B—IL23-mediated signaling events—IL17A—celiac disease	0.00595	0.0106	CbGpPWpGaD
Minocycline—MMP9—lymphoid tissue—celiac disease	0.00581	0.0133	CbGeAlD
Minocycline—ALOX5—smooth muscle tissue—celiac disease	0.00575	0.0132	CbGeAlD
Minocycline—MMP9—digestive system—celiac disease	0.00574	0.0131	CbGeAlD
Minocycline—IL1B—IFN-gamma pathway—PTPN2—celiac disease	0.00557	0.00989	CbGpPWpGaD
Minocycline—MMP9—blood—celiac disease	0.00547	0.0125	CbGeAlD
Minocycline—SLC22A11—digestive system—celiac disease	0.00544	0.0125	CbGeAlD
Minocycline—ALOX5—pancreas—celiac disease	0.00532	0.0122	CbGeAlD
Minocycline—SLC22A7—digestive system—celiac disease	0.00531	0.0122	CbGeAlD
Minocycline—CASP3—Allograft Rejection—IL12A—celiac disease	0.00531	0.00943	CbGpPWpGaD
Minocycline—IL1B—Cytokines and Inflammatory Response—IL10—celiac disease	0.00521	0.00925	CbGpPWpGaD
Minocycline—IL1B—liver—celiac disease	0.00513	0.0117	CbGeAlD
Minocycline—VEGFA—liver—celiac disease	0.00505	0.0116	CbGeAlD
Minocycline—IL1B—Allograft Rejection—IL12A—celiac disease	0.0048	0.00853	CbGpPWpGaD
Minocycline—VEGFA—HIF-2-alpha transcription factor network—ETS1—celiac disease	0.00464	0.00823	CbGpPWpGaD
Minocycline—ALOX5—lymphoid tissue—celiac disease	0.0046	0.0105	CbGeAlD
Minocycline—ALOX5—digestive system—celiac disease	0.00454	0.0104	CbGeAlD
Minocycline—CASP3—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—celiac disease	0.00452	0.00802	CbGpPWpGaD
Minocycline—ALOX5—blood—celiac disease	0.00433	0.0099	CbGeAlD
Minocycline—MMP9—liver—celiac disease	0.00428	0.00979	CbGeAlD
Minocycline—VEGFA—Beta1 integrin cell surface interactions—TGM2—celiac disease	0.00426	0.00756	CbGpPWpGaD
Minocycline—IL1B—Cytokines and Inflammatory Response—HLA-DRB1—celiac disease	0.00419	0.00744	CbGpPWpGaD
Minocycline—SLC22A11—liver—celiac disease	0.00406	0.00928	CbGeAlD
Minocycline—MMP9—Endochondral Ossification—RUNX3—celiac disease	0.00405	0.0072	CbGpPWpGaD
Minocycline—MMP9—CXCR4-mediated signaling events—RGS1—celiac disease	0.00405	0.00718	CbGpPWpGaD
Minocycline—SLC22A7—liver—celiac disease	0.00396	0.00906	CbGeAlD
Minocycline—VEGFA—Signaling events mediated by TCPTP—PTPN2—celiac disease	0.00393	0.00698	CbGpPWpGaD
Minocycline—IL1B—Toll-like Receptor Signaling Pathway—IL12A—celiac disease	0.00392	0.00695	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—ZMIZ1—celiac disease	0.00388	0.00689	CbGpPWpGaD
Minocycline—VEGFA—Platelet degranulation—PLEK—celiac disease	0.00372	0.00661	CbGpPWpGaD
Minocycline—CASP3—Allograft Rejection—IL17A—celiac disease	0.00358	0.00637	CbGpPWpGaD
Minocycline—VEGFA—Response to elevated platelet cytosolic Ca2+—PLEK—celiac disease	0.00355	0.0063	CbGpPWpGaD
Minocycline—VEGFA—Endochondral Ossification—RUNX3—celiac disease	0.00352	0.00625	CbGpPWpGaD
Minocycline—CASP3—TNF alpha Signaling Pathway—TNFAIP3—celiac disease	0.00343	0.00609	CbGpPWpGaD
Minocycline—ALOX5—liver—celiac disease	0.00338	0.00774	CbGeAlD
Minocycline—CASP3—Allograft Rejection—HLA-DPB1—celiac disease	0.00331	0.00587	CbGpPWpGaD
Minocycline—IL1B—Allograft Rejection—IL17A—celiac disease	0.00324	0.00576	CbGpPWpGaD
Minocycline—IL1B—Myometrial Relaxation and Contraction Pathways—RGS1—celiac disease	0.00323	0.00574	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—IL12A—celiac disease	0.0032	0.00568	CbGpPWpGaD
Minocycline—IL1B—TCR Signaling Pathway—SH2B3—celiac disease	0.0032	0.00568	CbGpPWpGaD
Minocycline—CASP3—Allograft Rejection—CTLA4—celiac disease	0.00313	0.00556	CbGpPWpGaD
Minocycline—IL1B—Regulation of toll-like receptor signaling pathway—IL12A—celiac disease	0.00306	0.00543	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—ETS1—celiac disease	0.003	0.00532	CbGpPWpGaD
Minocycline—IL1B—Allograft Rejection—HLA-DPB1—celiac disease	0.00299	0.00531	CbGpPWpGaD
Minocycline—IL1B—Cytokines and Inflammatory Response—CD4—celiac disease	0.00296	0.00525	CbGpPWpGaD
Minocycline—SLC22A11—SLC-mediated transmembrane transport—SLC9A4—celiac disease	0.00294	0.00523	CbGpPWpGaD
Minocycline—SLC22A8—blood—celiac disease	0.00293	0.0067	CbGeAlD
Minocycline—IL1B—TCR Signaling Pathway—IL17A—celiac disease	0.00292	0.00519	CbGpPWpGaD
Minocycline—CYCS—Transmembrane transport of small molecules—SLC9A4—celiac disease	0.00288	0.00512	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—RUNX3—celiac disease	0.00286	0.00508	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—FCGR2A—celiac disease	0.00286	0.00508	CbGpPWpGaD
Minocycline—IL1B—Allograft Rejection—CTLA4—celiac disease	0.00284	0.00504	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—MYO9B—celiac disease	0.0028	0.00498	CbGpPWpGaD
Minocycline—CASP3—Allograft Rejection—HLA-DQA1—celiac disease	0.00276	0.0049	CbGpPWpGaD
Minocycline—VEGFA—HIF-1-alpha transcription factor network—ETS1—celiac disease	0.00273	0.00484	CbGpPWpGaD
Minocycline—IL1B—IL12-mediated signaling events—CD8A—celiac disease	0.00272	0.00483	CbGpPWpGaD
Minocycline—SLC22A7—SLC-mediated transmembrane transport—SLC9A4—celiac disease	0.00267	0.00475	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—RUNX3—celiac disease	0.00259	0.0046	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—FCGR2A—celiac disease	0.00259	0.0046	CbGpPWpGaD
Minocycline—CASP3—Allograft Rejection—HLA-DQB1—celiac disease	0.00258	0.00458	CbGpPWpGaD
Minocycline—VEGFA—Signaling events mediated by VEGFR1 and VEGFR2—PTPN2—celiac disease	0.00257	0.00456	CbGpPWpGaD
Minocycline—IL1B—Regulation of toll-like receptor signaling pathway—MBL2—celiac disease	0.00251	0.00446	CbGpPWpGaD
Minocycline—IL1B—Allograft Rejection—HLA-DQA1—celiac disease	0.0025	0.00443	CbGpPWpGaD
Minocycline—CASP3—Allograft Rejection—IL10—celiac disease	0.00244	0.00433	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—ZMIZ1—celiac disease	0.00234	0.00415	CbGpPWpGaD
Minocycline—IL1B—Allograft Rejection—HLA-DQB1—celiac disease	0.00234	0.00415	CbGpPWpGaD
Minocycline—IL1B—IL23-mediated signaling events—CD4—celiac disease	0.0023	0.00408	CbGpPWpGaD
Minocycline—SLC22A8—SLC-mediated transmembrane transport—SLC9A4—celiac disease	0.00225	0.00399	CbGpPWpGaD
Minocycline—IL1B—Regulation of toll-like receptor signaling pathway—TNFAIP3—celiac disease	0.00223	0.00396	CbGpPWpGaD
Minocycline—IL1B—IL12-mediated signaling events—HLA-DRB1—celiac disease	0.00221	0.00393	CbGpPWpGaD
Minocycline—IL1B—Allograft Rejection—IL10—celiac disease	0.00221	0.00392	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—IL17A—celiac disease	0.00216	0.00384	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—HLA-DPB1—celiac disease	0.00199	0.00354	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—PTPN2—celiac disease	0.00199	0.00353	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—FCGR2A—celiac disease	0.00199	0.00353	CbGpPWpGaD
Minocycline—IL1B—TCR Signaling Pathway—CD8A—celiac disease	0.00196	0.00349	CbGpPWpGaD
Minocycline—CASP3—Allograft Rejection—HLA-DRB1—celiac disease	0.00196	0.00348	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—CTLA4—celiac disease	0.00189	0.00335	CbGpPWpGaD
Minocycline—SLC22A6—SLC-mediated transmembrane transport—SLC9A4—celiac disease	0.00187	0.00333	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—IL10—celiac disease	0.00186	0.00331	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—ETS1—celiac disease	0.00185	0.00329	CbGpPWpGaD
Minocycline—CASP3—Allograft Rejection—CD80—celiac disease	0.00181	0.00322	CbGpPWpGaD
Minocycline—IL1B—Allograft Rejection—HLA-DRB1—celiac disease	0.00178	0.00315	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—HLA-DPB1—celiac disease	0.00174	0.00309	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—RUNX3—celiac disease	0.00173	0.00306	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—SH2B3—celiac disease	0.00171	0.00304	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—HLA-DQA1—celiac disease	0.00166	0.00295	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—PLEK—celiac disease	0.00165	0.00293	CbGpPWpGaD
Minocycline—IL1B—Allograft Rejection—CD80—celiac disease	0.00164	0.00291	CbGpPWpGaD
Minocycline—CASP1—Immune System—MYO9B—celiac disease	0.00163	0.0029	CbGpPWpGaD
Minocycline—IL1B—IL12-mediated signaling events—CD4—celiac disease	0.00156	0.00277	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—HLA-DQB1—celiac disease	0.00155	0.00276	CbGpPWpGaD
Minocycline—CASP1—Immune System—ICOS—celiac disease	0.00155	0.00275	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—SLC9A4—celiac disease	0.0015	0.00266	CbGpPWpGaD
Minocycline—CASP1—Immune System—ICOSLG—celiac disease	0.00148	0.00262	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—IL10—celiac disease	0.00147	0.00261	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—HLA-DQA1—celiac disease	0.00145	0.00258	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—IL10—celiac disease	0.00141	0.00251	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—HLA-DQB1—celiac disease	0.00136	0.00241	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—SLC9A4—celiac disease	0.00136	0.00241	CbGpPWpGaD
Minocycline—CYCS—Metabolism—LCT—celiac disease	0.00135	0.0024	CbGpPWpGaD
Minocycline—IL1B—Toll-like Receptor Signaling Pathway—CD80—celiac disease	0.00134	0.00238	CbGpPWpGaD
Minocycline—CASP1—Immune System—TNFRSF14—celiac disease	0.00132	0.00234	CbGpPWpGaD
Minocycline—MMP9—CXCR4-mediated signaling events—HLA-DRB1—celiac disease	0.0013	0.0023	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—MBL2—celiac disease	0.00129	0.00229	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—IL10—celiac disease	0.00128	0.00227	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—PTPN2—celiac disease	0.00124	0.00221	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—ARHGAP31—celiac disease	0.0012	0.00214	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—HLA-DRB1—celiac disease	0.00118	0.0021	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—FCGR2A—celiac disease	0.00116	0.00207	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—TNFAIP3—celiac disease	0.00114	0.00203	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—SLC9A4—celiac disease	0.00114	0.00203	CbGpPWpGaD
Minocycline—IL1B—TCR Signaling Pathway—CD4—celiac disease	0.00113	0.002	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—CD80—celiac disease	0.00109	0.00194	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—HLA-DPB1—celiac disease	0.00109	0.00193	CbGpPWpGaD
Minocycline—IL1B—Regulation of toll-like receptor signaling pathway—CD80—celiac disease	0.00104	0.00185	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—HLA-DRB1—celiac disease	0.00103	0.00183	CbGpPWpGaD
Minocycline—IL1B—Immune System—MYO9B—celiac disease	0.00102	0.00181	CbGpPWpGaD
Minocycline—IL1B—Immune System—ICOS—celiac disease	0.000967	0.00172	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—SLC9A4—celiac disease	0.000952	0.00169	CbGpPWpGaD
Minocycline—IL1B—Immune System—ICOSLG—celiac disease	0.000923	0.00164	CbGpPWpGaD
Minocycline—MMP9—CXCR4-mediated signaling events—CD4—celiac disease	0.000915	0.00162	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—HLA-DQA1—celiac disease	0.000907	0.00161	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—ETS1—celiac disease	0.0009	0.0016	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—IL10—celiac disease	0.000852	0.00151	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—PLEK—celiac disease	0.000851	0.00151	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—HLA-DQB1—celiac disease	0.000849	0.00151	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ARHGAP31—celiac disease	0.000835	0.00148	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—LCT—celiac disease	0.000833	0.00148	CbGpPWpGaD
Minocycline—IL1B—Immune System—TNFRSF14—celiac disease	0.000822	0.00146	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—CD80—celiac disease	0.000792	0.00141	CbGpPWpGaD
Minocycline—CASP1—Immune System—MBL2—celiac disease	0.00075	0.00133	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MYO9B—celiac disease	0.000729	0.00129	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ARHGAP31—celiac disease	0.000725	0.00129	CbGpPWpGaD
Minocycline—CASP1—Immune System—FCGR2A—celiac disease	0.000678	0.0012	CbGpPWpGaD
Minocycline—CASP1—Immune System—TNFAIP3—celiac disease	0.000665	0.00118	CbGpPWpGaD
Minocycline—CASP1—Immune System—PTPN2—celiac disease	0.00065	0.00115	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—CD80—celiac disease	0.000648	0.00115	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—HLA-DRB1—celiac disease	0.000645	0.00115	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TAGAP—celiac disease	0.000632	0.00112	CbGpPWpGaD
Minocycline—CASP1—Immune System—HLA-DPB1—celiac disease	0.000568	0.00101	CbGpPWpGaD
Minocycline—CASP1—Immune System—CTLA4—celiac disease	0.000539	0.000957	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—CD80—celiac disease	0.000535	0.00095	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—SH2B3—celiac disease	0.000535	0.00095	CbGpPWpGaD
Minocycline—CASP1—Immune System—CD79A—celiac disease	0.000514	0.000913	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—MYO9B—celiac disease	0.000506	0.000899	CbGpPWpGaD
Minocycline—CASP1—Immune System—HLA-DQA1—celiac disease	0.000474	0.000842	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—RGS1—celiac disease	0.00047	0.000834	CbGpPWpGaD
Minocycline—IL1B—Immune System—MBL2—celiac disease	0.000469	0.000832	CbGpPWpGaD
Minocycline—CASP1—Immune System—HLA-DQB1—celiac disease	0.000443	0.000788	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MYO9B—celiac disease	0.000439	0.00078	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TAGAP—celiac disease	0.000439	0.000779	CbGpPWpGaD
Minocycline—IL1B—Immune System—FCGR2A—celiac disease	0.000424	0.000753	CbGpPWpGaD
Minocycline—IL1B—Immune System—TNFAIP3—celiac disease	0.000416	0.000739	CbGpPWpGaD
Minocycline—CASP1—Immune System—CD8A—celiac disease	0.000414	0.000736	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—CD4—celiac disease	0.000408	0.000725	CbGpPWpGaD
Minocycline—IL1B—Immune System—PTPN2—celiac disease	0.000406	0.000721	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TAGAP—celiac disease	0.000381	0.000676	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CCR4—celiac disease	0.000363	0.000645	CbGpPWpGaD
Minocycline—IL1B—Immune System—HLA-DPB1—celiac disease	0.000355	0.000631	CbGpPWpGaD
Minocycline—CASP1—Immune System—HLA-DRB1—celiac disease	0.000337	0.000599	CbGpPWpGaD
Minocycline—IL1B—Immune System—CTLA4—celiac disease	0.000337	0.000598	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—RGS1—celiac disease	0.000326	0.000579	CbGpPWpGaD
Minocycline—IL1B—Immune System—CD79A—celiac disease	0.000321	0.00057	CbGpPWpGaD
Minocycline—CASP1—Immune System—CD80—celiac disease	0.000312	0.000553	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CCR3—celiac disease	0.000309	0.000548	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—SH2B3—celiac disease	0.000301	0.000534	CbGpPWpGaD
Minocycline—IL1B—Immune System—HLA-DQA1—celiac disease	0.000296	0.000526	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—RGS1—celiac disease	0.000283	0.000503	CbGpPWpGaD
Minocycline—IL1B—Immune System—HLA-DQB1—celiac disease	0.000277	0.000492	CbGpPWpGaD
Minocycline—IL1B—Immune System—CD8A—celiac disease	0.000259	0.00046	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CCR4—celiac disease	0.000252	0.000448	CbGpPWpGaD
Minocycline—CASP1—Immune System—CD4—celiac disease	0.000238	0.000422	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CCR4—celiac disease	0.000219	0.000388	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CCR3—celiac disease	0.000214	0.000381	CbGpPWpGaD
Minocycline—IL1B—Immune System—HLA-DRB1—celiac disease	0.000211	0.000374	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—SH2B3—celiac disease	0.000209	0.000371	CbGpPWpGaD
Minocycline—IL1B—Immune System—CD80—celiac disease	0.000195	0.000346	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CCR3—celiac disease	0.000186	0.00033	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SH2B3—celiac disease	0.000181	0.000322	CbGpPWpGaD
Minocycline—IL1B—Immune System—CD4—celiac disease	0.000149	0.000264	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CD80—celiac disease	0.000139	0.000247	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CD80—celiac disease	9.66e-05	0.000171	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CD80—celiac disease	8.38e-05	0.000149	CbGpPWpGaD
